9 / 298
A
nais
do
XX C
ongresso
B
rasileiro
da
S
ociedade
B
rasileira
de
T
ransplante
de
M
edula
Ó
ssea
| R
ev
. A
ssoc
. M
ed
. B
ra
. 2016; 62 (
suppl
. 1)
9
Comparison of haploidentical transplant using post-transplant cyclophosphamide with allogeneic
10x10 HLA compatible transplant..........................................................................................71
A
ndreza
A
lice
F
eitosa
R
ibeiro
* (H
ospital
I
sraelita
A
lbert
E
instein
), L
ucila
N
assif
K
erbauy
(H
ospital
I
sraelita
A
lbert
E
instein
), I
racema
E
steves
(H
ospital
I
sraelita
A
lbert
E
instein
), M
organi
R
odrigues
(H
ospital
I
sraelita
A
lbert
E
instein
), J
uliana
F
olloni
(H
ospital
I
sraelita
A
lbert
E
instein
), C
inthya
C
orrêa
da
S
ilva
(H
ospital
I
sraelita
A
lbert
E
instein
), J
airo
J
ose
do
N
ascimento
S
obrinho
(H
ospital
I
sraelita
A
lbert
E
instein
), J
ose
M
auro
K
utner
(H
ospital
I
sraelita
A
lbert
E
instein
), F
abio
R
odrigues
K
erbauy
(H
ospital
I
sraelita
A
lbert
E
instein
)
e
N
elson
H
amerschlak
(H
ospital
I
sraelita
A
lbert
E
instein
)
Epidemiological analysis of allogeneic hematopoietic stem cell transplantations in Brazil...........72
S
tela
de
C
astro
F
reitas
* (U
nichristus
), N
ágila
A
lves
L
ima
(U
nichristus
), M
elina
de
P
aiva
B
ezerra
(U
nichristus
), V
inícius
T
orres
B
ezerra
(U
nichristus
), L
arissa
C
astro
F
irmino
(U
nichristus
), B
eatriz
de
S
ousa
S
ampaio
(U
nichristus
), F
rancisco
W
illamy
P
edrosa
A
lves
F
ilho
(U
nichristus
), K
amilla
do
R
êgo
C
haves
(U
nichristus
), I
ana
F
ernanda
S
ousa
M
achado
(U
nichristus
)
e
R
osane
A
lice
B
arbosa
B
omfim
de
M
orais
(U
nichristus
)
Use of post-transplant cyclophosphamide for primary immunodeficiencies: experience of 20
patients in three bone marrow transplant centers in Curitiba-PR. .............................................73
S
amantha
N
ichele
(H
ospital
de
C
linicas
U
fpr
), L
isandro
L
ima
R
ibeiro
* (H
ospital
de
C
linicas
U
fpr
), G
isele
L
oth
(H
ospital
N
ossa
S
enhora
das
G
raças
), C
ilmara
K
uwahara
(H
ospital
I
nfantil
P
equeno
P
ríncipe
), A
na
L
uiza
F
abro
(H
ospital
I
nfantil
P
equeno
P
ríncipe
),
M
iriam
B
eltrame
(H
ospital
de
C
linicas
U
fpr
), A
driana
K
oliski
(H
ospital
de
C
linicas
U
fpr
), R
icardo
P
asquini
(H
ospital
de
C
linicas
U
fpr
)
e
C
armem
B
onfim
(H
ospital
de
C
linicas
U
fpr
)
Quality of life in patients with sickle-cell anemia undergoing HSCT: a longitudinal study.............74
É
rika
A
rantes
de
O
liveira
C
ardoso
* (F
fclrp
-
usp
), J
uliana
T
omé
G
arcia
(HCFMRP-USP), A
na
L
uisa
C
arvalho
G
uimarães
(HCFMRP-USP),
A
na
B
eatriz
P
ereira
L
ima
S
tracieri
(HCFMRP-USP), F
abiano
P
ieroni
(HCFMRP-USP), C
arlos
E
duardo
S
etanni
G
recco
, (HCFMRP-USP),
R
enato
C
unha
(HCFMRP-USP), M
aria
C
arolina
de
O
liveira
(HCFMRP-USP), M
anoel
A
ntonio
dos
S
antos
(FFCLRP-USP)
e
B
elinda
P
into
S
imões
(HCFMRP-USP)
POSTER PRESENTATIONS
Hematology - Basic Area.......................................................................................................75
Hematology/pediatric transplantation ...................................................................................83
Hemotherapy. ......................................................................................................................85
Infections............................................................................................................................89
Histocompatibility................................................................................................................99
Multidisciplinary (Nursing, Psychology, Physical Therapy, Occupational Therapy, Pharmacy, Oral
Medicine, Social Services)..................................................................................................104
Cell therapy.......................................................................................................................130
Hematology – malignant diseases........................................................................................144
Allogeneic Transplantation .................................................................................................154
Histocompatibility..............................................................................................................186
Multidisciplinary (Nursing, Psychology, Physical Therapy, Occupational Therapy, Pharmacy, Oral
Medicine, Social Services)..................................................................................................190
Cell therapy.......................................................................................................................208
Autologous Transplantation.................................................................................................221
Histocompatibilidade..........................................................................................................244
Multidisciplinary (Nursing, Psychology, Physical Therapy, Occupational Therapy, Pharmacy, Oral
Medicine, Social Services)..................................................................................................249
Allogeneic Transplantation..................................................................................................273
Cell therapy.......................................................................................................................276
SUMMARY